Vasily Medvedev - Head of Development, Exothera

Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app

Network Power<100 people

Roles

🔥100%

Startup Founder

💸100%

Marketing

✔️100%

Geos

🇨🇦100%

Canada

Work Background

EXOTHERAHead of Development

May. 2020Charleroi, Walloon Region, BelgiumAccountable for the spectra of development activities within a CDMO, ensuring that the Company’s business requirements are properly translated to the development practices and deliverables. Leading development groups of upstream, downstream, analytics, CMC, technology transfer & laboratory support through the pipeline of various biologics process development projects focusing on viral vectors and vector vaccines.

UNIVERCELLSProcess Development Manager

Mar. 2019 - May. 2020Brussels Area, BelgiumLeading and managing biotherapeutics process development team of 17 with accountability in process & analytics for biosimilars, process scale-up and transfer. Responsibilities in CMC and overall preclinical product development for biosimilar candidates with focus on technological innovations and process platformization.

UNIVERCELLSSenior Bioprocess Architect

Mar. 2018 - Mar. 2019Charleroi Area, BelgiumHaving joined the company at a stage of a start-up, I led installation of protein therapeutics skills and capacities resulting in creating a business unit focused on biosimilar antibodies processes and technologies.

UNIVERCELLSBioprocess Engineer

Aug. 2016 - Mar. 2018Gosselies, BelgiumWhile leading purification projects, I helped to create a purification IP portfolio for the company combining processing methods and equipment and set-up associated production platform for CHO-expressed monoclonal antibodies. Largely supported development of purification techniques for viral targets (internal and for external Clients).

AlphaMab Co.Intern

Nov. 2012 - May. 2014Suzhou, Jiangsu, ChinaPurification process development for mammalian- and microbial- expressed proteins. Purification of monoclonal antibodies, purification scale-up, pilot, and clinical manufacturing using disposable bioprocessing technologies.

Gallus BioPharmaceuticalsIntern

Mar. 2012 - Sep. 2012Greater St. Louis AreaBiologics process development and pilot production using disposable technologies based FlexFactory™ platform. Site commissioning, engineering runs and transfer experience.

R-PharmBioprocess Engineer

Oct. 2011 - Aug. 2016Yaroslavl Region, Russian FederationPurification process development, scale-up and transfer to manufacturing of novel monoclonal antibodies and fusion proteins. Pilot processing in a fully single-use architecture. Support to CMC and product development. I led the downstream works when installing a novel capacity for biologics drug substance development and manufacturing. Largely contributed to on-time commissioning of therapeutic proteins manufacturing site with fully single-use architecture. I worked on purification transfer-in for several novel monoclonals and fusion proteins & had successfully developed several purification processes up to a pilot scale.